✦ LIBER ✦

A phase 1 dose-escalation study of ARRY-520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias

✍ Scribed by Hanna Jean Khoury; Guillermo Garcia-Manero; Gautam Borthakur; Tapan Kadia; Maria Cielo Foudray; Martha Arellano; Amelia Langston; Beverly Bethelmie-Bryan; Selena Rush; Kevin Litwiler; Sharon Karan; Heidi Simmons; Adam I. Marcus; Mieke Ptaszynski; Hagop Kantarjian

Book ID: 112066989
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 305 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26664

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of ispinesib, a kinesin

A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours

✍ Blagden, S P; Molife, L R; Seebaran, A; Payne, M; Reid, A H M; Protheroe, A S; V 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 150 KB

640 POSTER Phase I study of ispinesib (S

640 POSTER Phase I study of ispinesib (SB-715992), a kinesin spindle protein inhibitor, in combination with capecitabine in patients with advanced solid tumors

✍ J. Rodon; E. Till; A. Patnaik; C. Takimoto; M. Beeram; D. Williams; C. Bowen; J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Activity of the oral MEK inhibitor trame

Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial

✍ Gerald S Falchook; Karl D Lewis; Jeffrey R Infante; Michael S Gordon; Nicholas J 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 225 KB

A phase I dose escalating study of the a

A phase I dose escalating study of the angiogenesis inhibitor thrombospondin-1 mimetic (abt-510) in patients with advanced cancer

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 266 KB

390 POSTER A Phase I dose-escalation stu

390 POSTER A Phase I dose-escalation study of XL228, a potent IGF1R / Src inhibitor, in patients with advanced malignancies

✍ C. Britten; D.C. Smith; L.A. Bui; D.O. Clary; H.I. Hurwitz 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Phase I dose escalation study of MK-0457

Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors

✍ Anne M. Traynor; Maureen Hewitt; Glenn Liu; Keith T. Flaherty; Jason Clark; Stev 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 252 KB